Order Article Reprints

Oltra SS, Cejalvo JM, Tormo E, Albanell M, Ferrer A, Nacher M, Bermejo B, Hernando C, Chirivella I, Alonso E, et al. HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers. 2020; 12(2):412. https://doi.org/10.3390/cancers12020412

Oltra, Sara S., Juan Miguel Cejalvo, Eduardo Tormo, Marta Albanell, Ana Ferrer, Marta Nacher, Begoña Bermejo, Cristina Hernando, Isabel Chirivella, Elisa Alonso, and et al. 2020. "HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women" Cancers 12, no. 2: 412. https://doi.org/10.3390/cancers12020412

Oltra, S. S., Cejalvo, J. M., Tormo, E., Albanell, M., Ferrer, A., Nacher, M., Bermejo, B., Hernando, C., Chirivella, I., Alonso, E., Burgués, O., Peña-Chilet, M., Eroles, P., Lluch, A., Ribas, G., & Martinez, M. T. (2020). HDAC5 Inhibitors as a Potential Treatment in Breast Cancer Affecting Very Young Women. Cancers, 12(2), 412. https://doi.org/10.3390/cancers12020412